Experimental Challenge of Volunteers with Malaria

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Annals of Internal Medicine

• Publication date

  1997-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.7326/0003-4819-127-3-199708010-00010PMID 9245231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge.

  1997cited by this paper
• Measurement of Plasmodium falciparum growth rates in vivo: a test of malaria vaccines.

  1997cited by this paper
• A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.

  1997cited by this paper
• Perspectives on malaria vaccine development.

  1996cited by this paper
• Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine.

  1995cited by this paper
• Prophylaxis of Plasmodium falciparum Malaria with Azithromycin Administered to Volunteers

  1995cited by this paper
• Failure of Doxycycline as a Causal Prophylactic Agent against Plasmodium falciparum Malaria in Healthy Nonimmune Volunteers

  1994cited by this paper
• Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant.

  1994cited by this paper
• History of malaria in the United States Naval Forces at war: World War I through the Vietnam conflict.

  1993cited by this paper
• Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites.

  1993cited by this paper
• Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein.

  1991cited by this paper
• A model for Plasmodium falciparum sporozoite challenge and very early therapy of parasitaemia for efficacy studies of sporozoite vaccines.

  1988cited by this paper
• A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria

  1988cited by this paper
• Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

  1987cited by this paper
• Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine.

  1987cited by this paper
• Malaria transmitted to humans by mosquitoes infected from cultured Plasmodium falciparum.

  1986cited by this paper
• Sidelights on malaria in man obtained by subinoculation experiments.

  1947cited by this paper
• The Treatment of General Paresis by Inoculation of Malaria.

  1922cited by this paper

• Sex-based differences in Plasmodium infection in the control groups of controlled human malaria infection trials in malaria-naive populations in the USA and the Netherlands: a pooled analysis.

  2026cites this paper
• Five decades of clinical assessment of whole-sporozoite malaria vaccines

  2022cites this paper
• The Controlled Human Malaria Infection Experience at the University of Maryland.

  2019cites this paper
• Whole-Sporozoite Malaria Vaccines

  2017cites this paper
• Immune Response to Infection and Vaccination

  2017cites this paper
• Safety and Comparability of Controlled Human Plasmodium falciparum Infection by Mosquito Bite in Malaria-Naïve Subjects at a New Facility for Sporozoite Challenge

  2014cites this paper
• P. falciparum Enhances HIV Replication in an Experimental Malaria Challenge System

  2012cites this paper
• A quantitative analysis of transmission efficiency versus intensity for malaria

  2010cites this paper
• A Polyprotein Multi-Stage Malaria Vaccine : Clinical Trials

  2010cites this paper
• Chapter 65 – Malaria

  2009cites this paper
• Genetic complexity and population diversity of Plasmodium falciparum in the Peruvian Amazon

  2009cites this paper
• Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines

  2008cites this paper
• Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update.

  2007cites this paper
• The development of a multivalent DNA vaccine for malaria

  2004cites this paper
• Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine

  2003cites this paper
• Part A - Clinical Development of New Vaccines: Phase 1 and 2 Trials

  2003cites this paper
• TRIAL DESIGN FOR VACCINES

  2003cites this paper
• Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.

  2002cites this paper
• The ethical challenge of infection-inducing challenge experiments.

  2001cites this paper
• Parasitology into the 21st century.

  1999cites this paper
• Toward clinical trials of DNA vaccines against malaria

  1997cites this paper